Cas9 editing of ATXN1 in a spinocerebellar ataxia type 1 mice and human iPSC-derived neurons
Spinocerebellar ataxia type 1 (SCA1) is an adult-onset neurodegenerative disease caused by an expansion of the CAG repeat region of the ATXN1 gene. Currently there are no disease-modifying treatments; however, previous work has shown the potential of gene therapy, specifically RNAi, as a potential m...
Saved in:
Main Authors: | Kelly J. Fagan (Author), Guillem Chillon (Author), Ellie M. Carrell (Author), Elisa A. Waxman (Author), Beverly L. Davidson (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1
by: Mihai Miclăuș, et al.
Published: (2024) -
Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons
by: Priyanka Mishra, et al.
Published: (2024) -
Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs
by: Kosuke Matsuzono, et al.
Published: (2017) -
Spinocerebellar Ataxia
Published: (2012) -
Spinocerebellar Ataxia
by: J Gordon Millichap
Published: (1988)